A61P 5/40
Mineralocorticosteroids
Official title: Mineralocorticosteroids, e.g. aldosterone; Drugs increasing or potentiating the activity of mineralocorticosteroids
A61P5/40 (Mineralocorticosteroids) appears on 262 US grants and 443 published applications in this corpus.
Search patents in A61P- Granted patents
- 262
- Published applications
- 443
- Assignees
- 168
- Inventors
- 919
- Latest grant
- 11 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 2 | 0 |
| 1998 | 2 | 0 |
| 1999 | 1 | 0 |
| 2000 | 2 | 0 |
| 2001 | 2 | 1 |
| 2002 | 3 | 6 |
| 2003 | 6 | 14 |
| 2004 | 2 | 19 |
| 2005 | 5 | 17 |
| 2006 | 4 | 26 |
| 2007 | 5 | 40 |
| 2008 | 10 | 34 |
| 2009 | 15 | 41 |
| 2010 | 24 | 32 |
| 2011 | 21 | 26 |
| 2012 | 22 | 20 |
| 2013 | 26 | 18 |
| 2014 | 13 | 20 |
| 2015 | 8 | 15 |
| 2016 | 15 | 27 |
| 2017 | 18 | 16 |
| 2018 | 12 | 13 |
| 2019 | 7 | 15 |
| 2020 | 13 | 9 |
| 2021 | 4 | 10 |
| 2022 | 10 | 4 |
| 2023 | 3 | 7 |
| 2024 | 3 | 9 |
| 2025 | 2 | 4 |
By publication year. Applications have been published since 2001.
Recent patents
- Modified anti-inflammatory proteins and method of use11 Nov 2025US 12,466,873 B2James Cook University
- Aldosterone synthase inhibitor21 Jan 2025US 12,202,827 B2Damian Pharma AG
- Antibodies to L-type voltage gated channels and related methods3 Sep 2024US 12,077,582 B2The University of British Columbia
- Modified anti-inflammatory proteins and method of use7 May 2024US 11,976,108 B2James Cook University
- Glycyrrhetinic acid derivatives for use in treating hyperkalemia2 Jan 2024US 11,858,959 B2Ardelyx, Inc.
- Pyranopyridine compound, process for preparing the same, pharmaceutical composition and use thereof27 Nov 2025US 2025/0361240 A1Zhejiang Yangli Pharmaceutical Technology Co., Ltd.
- Cyclic polypeptide for the treatment of pha type 1b10 Jul 2025US 2025/0222065 A1Apeptico Forschung Und Entwicklung GmbH
- Bromodomain inhibitors15 May 2025US 2025/0152600 A1
- Aldosterone synthase inhibitor24 Apr 2025US 2025/0129071 A1Damian Pharma AG
- Humanized anti-cd19 antibodies and their use in treatment of oncology, transplantation and autoimmune disease19 Dec 2024US 2024/0417460 A1Viela Bio, Inc.
Most cited
By later US patents
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions930US 6,248,363 B1Lipocine Inc. · 2001
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions684US 6,923,988 B2Lipocine Inc. · 2005
- Solid carriers for improved delivery of hydrophobic active ingredients in pharmaceutical compositions616US 6,569,463 B2Lipocine Inc. · 2003
- Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations234US 6,046,177 ACydex, Inc. · 2000
- Albumin fusion proteins comprising GLP-1 polypeptides198US 7,141,547 B2Human Genome Sciences, Inc. · 2006